Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Jonathan Rothberg, Ronald Lindsay, Ardy Arianpour, John Luckey

Premium

Jonathan Rothberg has resigned from his position as CEO of Life Technologies' Ion Torrent business, according to a filing with the US Securities and Exchange Commission. Ronnie Andrews, Life Tech's president of genetic and medical sciences, will oversee the Ion Torrent business in addition to continuing in his current role.


Sequenom's executive vice president of strategic planning Ronald Lindsay is cutting back to part-time hours, the company said in a US Securities and Exchange Commission filing this week. Lindsay will reduce his time commitment by half and will receive a pro-rated portion of his $358,000 salary. Lindsay also currently serves on the company's board of directors.


Ardy Arianpour is now senior vice president of business development at Ambry Genetics. Previously he was vice president of business development at the company. Prior to joining Ambry in 2009, he held several positions at Cogenics. He holds an MBA from the Marshall Goldsmith School of Management at Alliant International University/University of California, San Diego and a BS from the University of California, Irvine.


PathoGenetix has appointed John Luckey to be vice president of engineering. In the role, he will lead development and integration for the firm's Resolution Microbial Genotyping System.

Luckey previously was technical projects director with Roche NimbleGen, and he managed software development and instrumentation engineering activities at OpGen Technologies. He also founded GeneSys Technologies to market the BaseStation DNA Fragment Analyzer, which he designed and developed.

The Scan

Guidelines for Ancient DNA Work

More than two dozen researchers have developed new ethical guidelines for conducting ancient DNA research, which they present in Nature.

And Cleared

A UK regulator has cleared former UK Prime Minister David Cameron in concerns he should have registered as a consultant-lobbyist for his work with Illumina, according to the Financial Times.

Suit Over Allegations

The Boston Globe reports that David Sabatini, who was placed on leave from MIT after allegations of sexual harassment, is suing his accuser, the Whitehead Institute, and the institute's director.

Nature Papers on Esophageal Cancer, Origin of Modern Horses, Exome Sequencing of UK Biobank Participants

In Nature this week: genetic and environmental influences of esophageal cancer, domestic horse origin traced to Western Eurasian steppes, and more.